APA (7th ed.) Citation

Zhang, S., Zhang, N., Lin, J., Zhao, L., Jin, H., Gao, D., . . . Yu, Y. (2025). Management of multisystemic irAEs associated with atezolizumab/tiragolumab combination therapy in a patient with lung adenocarcinoma. Clinical Cancer Bulletin, 4(1), . https://doi.org/10.1007/s44272-025-00034-2

Chicago Style (17th ed.) Citation

Zhang, Shilong, et al. "Management of Multisystemic IrAEs Associated with Atezolizumab/tiragolumab Combination Therapy in a Patient with Lung Adenocarcinoma." Clinical Cancer Bulletin 4, no. 1 (2025). https://doi.org/10.1007/s44272-025-00034-2.

MLA (9th ed.) Citation

Zhang, Shilong, et al. "Management of Multisystemic IrAEs Associated with Atezolizumab/tiragolumab Combination Therapy in a Patient with Lung Adenocarcinoma." Clinical Cancer Bulletin, vol. 4, no. 1, 2025, https://doi.org/10.1007/s44272-025-00034-2.